scispace - formally typeset
M

Michael Schumacher

Researcher at University of Applied Sciences Western Switzerland

Publications -  154
Citations -  3724

Michael Schumacher is an academic researcher from University of Applied Sciences Western Switzerland. The author has contributed to research in topics: Multi-agent system & Autonomous agent. The author has an hindex of 28, co-authored 154 publications receiving 3130 citations. Previous affiliations of Michael Schumacher include Lahti University of Applied Sciences & Open University.

Papers
More filters
Proceedings Article

Secure and Trustable Electronic Medical Records Sharing using Blockchain.

TL;DR: A framework on managing and sharing EMR data for cancer patient care using blockchain to significantly reduce the turnaround time for EMR sharing, improve decision making for medical care, and reduce the overall cost is proposed.
Journal ArticleDOI

Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis

TL;DR: In vivo and in vitro, TRO19622 rescued motor neurons from axotomy-induced cell death in neonatal rats and promoted nerve regeneration following sciatic nerve crush in mice, suggesting a potential mechanism for its neuroprotective activity.
Posted Content

Secure and Trustable Electronic Medical Records Sharing using Blockchain

TL;DR: In this paper, a framework for managing and sharing electronic medical records (EMRs) for cancer patient care is proposed, which can significantly reduce the turnaround time for EMR sharing, improve decision making for medical care, and reduce the overall cost.
Journal ArticleDOI

Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis.

TL;DR: Loss-of-function analyses in zebrafish embryos show a key role for Wnt/β-catenin signaling in the expression of myelin genes and in myelin sheath compaction, both in the peripheral and central nervous systems.
Journal ArticleDOI

Etifoxine improves peripheral nerve regeneration and functional recovery

TL;DR: This work demonstrates that etifoxine, a clinically approved drug already used for the treatment of anxiety disorders, is remarkably efficient in promoting acceleration of peripheral nerve regeneration and functional recovery.